Brief: Cathay International Says Lansen Pharmaceutical's Hou Song To Step Down As CFO
Oct 12 (Reuters) - Cathay International Holdings Ltd
CTI.L :
* UNIT LANSEN PHARMACEUTICAL HAS ANNOUNCED TODAY THAT HOU
SONG
RESIGNED AS AN EXECUTIVE DIRECTOR OF LANSEN & AS CFO
* HOU HAS CONFIRMED THAT HE HAS NO DISAGREEMENT WITH BOARD
OF
LANSEN
* LANSEN SAYS HOU SONG RESIGNATION WITH EFFECT FROM 20
OCTOBER
2018
Source text for Eikon: ID:nRSL8916Da
Further company coverage: CTI.L
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Lansen Pharmaceutical Holdings
See all newsBrief: Lansen Pharmaceutical Says Stock Exchange Approved Withdrawal Of Listing Of Shares From 9 AM, 19 Dec
Brief: Lansen Pharmaceutical Updates Withdrawal Of Listing Of Shares On Stock Exchange
Brief: Lansen Pharmaceutical Says Trading In Shares Will Be Halted
Brief: Lansen Pharmaceutical Posts FY Revenue Of $65.6 Mln VS $54.2 Mln
Brief: Lansen Pharmaceutical Sees Net Profit Attributable Of Approximately $8.1 Million For Year